{"id":"CHEMBL1024","canonicalSmiles":"O=P1(NCCCl)OCCCN1CCCl","inchiKey":"HOMGKSMUEGBAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IFOSFAMIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ifex","Ifosfamide","Ifsofamide","Mitoxana"],"synonyms":["Ifosfamide","MJF 9325","MJF-9325","NSC-109724","Z-4942","Z4942"],"crossReferences":{"DailyMed":["ifosfamide"],"PubChem":["11112546","144204090","144209013","144213092","170464854","174007357","301170","56463644"],"Wikipedia":["Ifosfamide"],"drugbank":["DB01181"],"chEBI":["5864"]},"childChemblIds":["CHEMBL342466"],"count":59,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for cancer and neoplasm and has 57 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL103667","canonicalSmiles":"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1","inchiKey":"MVCOAUNKQVWQHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIRB 796 BS","BIRB-796","BIRB-796 BS","Birb-796","Doramapimod"],"crossReferences":{"PubChem":["103904828","124950164","144206937","170466618","50100090"],"drugbank":["DB03044"],"chEBI":["40953"]},"count":2,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1108","canonicalSmiles":"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1","inchiKey":"RMEDXOLNCUSCGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DROPERIDOL","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dridol","Droleptan","Droperidol","Inapsine"],"synonyms":["Droperidol","MCN-JR-4749","NSC-169874","R-4749"],"crossReferences":{"DailyMed":["droperidol"],"PubChem":["11112409","124882342","144204012","170464722","26719691","26748461","56463295","855921"],"Wikipedia":["Droperidol"],"drugbank":["DB00450"],"chEBI":["4717"]},"count":2,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_1000864","EFO_0004888","EFO_0005407","HP_0002013","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for psychosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1164729","canonicalSmiles":"Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O","inchiKey":"BQSJTQLCZDPROO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FEBUXOSTAT","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adenuric","Uloric"],"synonyms":["Febuxostat","TMX-67"],"crossReferences":{"DailyMed":["febuxostat"],"PubChem":["124893781","144206555","170465220"],"Wikipedia":["Febuxostat"],"drugbank":["DB04854"]},"count":7,"approvedIndications":["EFO_0009104","EFO_0004274"],"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0009104","EFO_0004253","EFO_0004274","EFO_0001645","EFO_0001359","Orphanet_976","EFO_0000319","EFO_1001479","EFO_0000537","EFO_0003913"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for hyperuricemia and gout and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1194345","canonicalSmiles":"N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F","inchiKey":"SOSYXEPELJIJHZ-RNCFNFMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1194345","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07021"]},"childChemblIds":["CHEMBL562188","CHEMBL552068"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200359","canonicalSmiles":"COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1","inchiKey":"GPTONYMQFTZPKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETER","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"year":1988},"tradeNames":["Bayrena","Sulfametin","Sulfametoxydiazine","Sulla","Sulphamethoxydiazine","Ultrax"],"synonyms":["AHR-857","Sulfameter","Sulfametin","Sulfametoxydiazine","Sulphamethoxydiazine"],"crossReferences":{"PubChem":["11112435","144204029","170465428","26748523","855817"],"Wikipedia":["Sulfametoxydiazine"],"drugbank":["DB06821"],"chEBI":["53727"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1966 and is indicated for bacterial disease. It was withdrawn in Germany  in 1988."}
{"id":"CHEMBL1200377","canonicalSmiles":"CC(N)Cc1ccccc1.NC(CC(=O)O)C(=O)O","inchiKey":"DYOBNLAYPQSBLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPHETAMINE ASPARTATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amfetamine aspartate","Amphetamine aspartate"],"crossReferences":{"DailyMed":["amphetamine%20aspartate"]},"count":1,"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1200413","canonicalSmiles":"Cl.c1ccc2c(c1)CCCC2C1=NCCN1","inchiKey":"BJORNXNYWNIWEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROZOLINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1266","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tyzine"],"synonyms":["Tetrahydrozoline hydrochloride","Tetrahydrozoline nitrate","Tetryzoline","Tetryzoline hydrochloride"],"crossReferences":{"PubChem":["170464943","26747671","50107052","56424102","855698"]},"count":2,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MP_0001845","EFO_0000678"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 2 investigational indications."}
{"id":"CHEMBL1200760","canonicalSmiles":"O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]","inchiKey":"CKMOQBVBEGCJGW-LLIZZRELSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BALSALAZIDE DISODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201346","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Balsalazide disodium","Colazal","Colazide","Giazo"],"synonyms":["BX-661A","BX661A","Balsalazide disodium","Balsalazide disodium dihydrate","Balsalazide disodium salt dihydrate","Balsalazide sodium","Balsalazine"],"crossReferences":{"DailyMed":["balsalazide%20disodium"]},"count":1,"approvedIndications":["EFO_0000729"],"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for ulcerative colitis."}
{"id":"CHEMBL1200991","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4c(c3)CCC4)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"QFWPXOXWAUAYAB-XZVIDJSISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN INDANYL SODIUM","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geocillin"],"synonyms":["CP-15,464-2","CP-15464-2","Carbenicillin indanyl sodium","Carindacillin sodium","Carindacillin sodium salt"],"crossReferences":{"Wikipedia":["Carindacillin"],"chEBI":["31358"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972 and has 1 investigational indication."}
{"id":"CHEMBL1201011","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl","inchiKey":"IBBLRJGOOANPTQ-JKVLGAQCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINAPRIL HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1592","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accupril","Accupro","Quinapril hydrochloride","Quinil"],"synonyms":["CI 906","CI-906","Quinapril hydrochloride"],"crossReferences":{"DailyMed":["quinapril%20hydrochloride"],"PubChem":["144204934","144207588","170465312","49648461"],"chEBI":["8714"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201130","canonicalSmiles":"C[N+](C)(C)CC(=O)O.[Cl-]","inchiKey":"HOPSCVCBEOCPJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL95889","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acidol pepsin","Cystadane"],"synonyms":["Betaine HCl","Betaine hydrochloride","Lycine hydrochloride","NSC-32191","NSC-3976"],"crossReferences":{"PubChem":["144204926","144212459","170464844","26748661","50105912","56462965"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201175","canonicalSmiles":"N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1.NC(CO)(CO)CO","inchiKey":"KUGJPYZIWCRREB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODOXAMIDE TROMETHAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201266","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alomide"],"synonyms":["U-42585E"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201643","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PROMPT PURIFIED PORK","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Semilente"],"synonyms":["Insulin zinc susp prompt purified pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201653","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PURIFIED PORK","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lente","Lente iletin ii (pork)"],"synonyms":["Insulin zinc susp purified pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201741","canonicalSmiles":"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"IUDQMMSLVSVGDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLANZAPINE PAMOATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL715","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zyprexa Relprevv"],"synonyms":["Olanzapine pamoate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201799","canonicalSmiles":"C=CCN.ClCC1CO1.O=C(O)O","inchiKey":"PADGNZFOVSZIKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVELAMER CARBONATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201798","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renvela"],"synonyms":["GT-335-012","GT335-012","Sevelamer carbonate"],"crossReferences":{"DailyMed":["sevelamer%20carbonate"],"DrugCentral":["4331"]},"count":4,"approvedIndications":["EFO_0003884"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for chronic kidney disease and has 3 investigational indications."}
{"id":"CHEMBL1213492","canonicalSmiles":"CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1","inchiKey":"YALNUENQHAQXEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIVINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Givinostat"],"crossReferences":{"drugbank":["DB12645"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1230051","canonicalSmiles":"O=C(Nc1cccc(-c2n[nH]c3ccc(-c4nc[nH]n4)cc23)c1)c1ccco1","inchiKey":"LMDMJDCLPIVGQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230051","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231418","canonicalSmiles":"CC1=C(Br)C(=O)C(C(C)C)=C(Br)C1=O","inchiKey":"GHHZELQYJPWSMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Dibromothymoquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04646"],"chEBI":["19371"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231861","canonicalSmiles":"CC(C)(O)C#N","inchiKey":"MWFMGBPGAXYFAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLKETONE CYANOHYDRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208688","144213573"],"drugbank":["DB02203"],"chEBI":["15348"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232328","canonicalSmiles":"CCOP(O)(=S)OCC","inchiKey":"PKUWKAXTAVNIJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O,O-DIETHYL S-HYDROGEN PHOSPHOROTHIOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07674"],"chEBI":["28006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234355","canonicalSmiles":"CC(C)(CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)O","inchiKey":"LTYOQGRJFJAKNA-DVVLENMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALONYL-COENZYME A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04524"],"chEBI":["15531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236122","canonicalSmiles":"COC(=O)c1cc(OC)c(O)c(OC)c1","inchiKey":"ZMXJAEGJWHJMGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SYRINGATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08589"],"chEBI":["45820"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237082","canonicalSmiles":"CNC1(C)C2CCC(C2)C1(C)C.Cl","inchiKey":"PKVZBNCYEICAQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECAMYLAMINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL267936","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inversine","Mecamylamine hydrochloride"],"synonyms":["Mecamylamine chloride","Mecamylamine hydrochloride"],"crossReferences":{"DailyMed":["mecamylamine%20hydrochloride"],"PubChem":["50106687","50106688","50106689"]},"count":1,"linkedTargets":{"rows":["ENSG00000117971","ENSG00000080644"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and has 1 investigational indication."}
{"id":"CHEMBL1255778","canonicalSmiles":"Cl.NC(CO)C(=O)NNCc1ccc(O)c(O)c1O","inchiKey":"ULFCBIUXQQYDEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENSERAZIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1096979","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benserazide HCl"],"crossReferences":{"PubChem":["144204124","170465804","26747460","50105973","56424021","855739"],"chEBI":["31262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256671","canonicalSmiles":"CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C.Cl","inchiKey":"GQJUGJHJUZSJLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAZOLATE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL356388","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etazolate hydrochloride","SO 20009"],"crossReferences":{"PubChem":["144204777","170466445","50106219"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1257115","canonicalSmiles":"CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl","inchiKey":"GELMUARXROJGSO-LFMIJCLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIMELDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL37744","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["46500342","573216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL127214","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(-c2ccsc2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(-c2ccsc2)cc1)C(=O)N[C@H](C(=O)NC)C(C)C)C(C)C","inchiKey":"AJZAPEZJWWQJHC-UWNKZCSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL127214","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142130","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DUSHUSLJJMDGTE-ZJPMUUANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyproterone"],"crossReferences":{"PubChem":["144204968"],"Wikipedia":["Cyproterone_acetate"],"chEBI":["50742"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL143305","canonicalSmiles":"Cc1cc(CCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"TUGBWRGTMLOFAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL143305","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1471","canonicalSmiles":"C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"ATALOFNDEOCMKK-OITMNORJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APREPITANT","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aprepitant","Cinvanti","Emend"],"synonyms":["Aprepitant","L-754,030","MK-0869","MK-869"],"crossReferences":{"DailyMed":["aprepitant"],"Wikipedia":["Aprepitant"],"drugbank":["DB00673"],"chEBI":["499361"]},"count":21,"approvedIndications":["EFO_0006911","HP_0002017","EFO_0004888","EFO_0000311","HP_0002018"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0004240","HP_0000989","EFO_0002610","MONDO_0002009","MONDO_0007254","EFO_1000948","EFO_0003829","HP_0002018","EFO_0007191","EFO_0000565","EFO_0003144","HP_0002017","HP_0002013","EFO_0000514","MONDO_0002715","EFO_0000616","EFO_0006911","MONDO_0008170","EFO_0000222","EFO_0003843","EFO_0003060","EFO_0000311","MONDO_0100096","EFO_0000764","EFO_0004888","EFO_0000574","EFO_0001378","EFO_0005611","EFO_0000519"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 5 approved and 16 investigational indications."}
{"id":"CHEMBL1475","canonicalSmiles":"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1","inchiKey":"FMHHVULEAZTJMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIOXSALEN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trisoralen"],"synonyms":["Trioxsalen","Trioxysalen"],"crossReferences":{"PubChem":["11112550","114185","144204092","170465339","174006210","26748294","49647255"],"Wikipedia":["Trioxsalen"],"drugbank":["DB04571"],"chEBI":["28329"]},"count":1,"approvedIndications":["EFO_0000676"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964 and is indicated for psoriasis."}
{"id":"CHEMBL1531864","canonicalSmiles":"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1.Cl.Cl","inchiKey":"FFNMBRCFFADNAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRENZEPINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL9967","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LS 519 C12","Pirenzepine hydrochloride"],"crossReferences":{"PubChem":["50106842"],"chEBI":["32014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL158766","canonicalSmiles":"Cc1ccc(O)c(O)c1","inchiKey":"ZBCATMYQYDCTIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL158766","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207830"],"drugbank":["DB04120"],"chEBI":["17254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1589","canonicalSmiles":"CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1","inchiKey":"VGZSUPCWNCWDAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOHEXAMIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetohexamide","Dimelor","Dymelor"],"synonyms":["33006","Acetohexamide"],"crossReferences":{"PubChem":["11110689","11112460","144203618","144209220","144213052","170465411","17390067","50105548","56463352"],"Wikipedia":["Acetohexamide"],"drugbank":["DB00414"],"chEBI":["28052"]},"count":2,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0001059","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL1628605","canonicalSmiles":"[3H]C(CCN(C)C)C1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WSEQXVZVJXJVFP-OAWTUDSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]CITALOPRAM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL549","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[3H]-Citalopram"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1630563","canonicalSmiles":"O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2","inchiKey":"ZXSGSFMORAILEY-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TBA-354","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TBA 354","Tba-354"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL164","canonicalSmiles":"O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"IKMDFBPHZNJCSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MYRICETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-407290"],"crossReferences":{"PubChem":["11111487","11111488","11111489","124880771","124880773","124880776","124880777","124880778","26753603","26753604","477075","50106561","50106562","50124232","56463598","85231140","90341245"],"Wikipedia":["Myricetin"],"drugbank":["DB02375"],"chEBI":["18152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL165372","canonicalSmiles":"O=[N+]([O-])c1ccc2[nH]ncc2c1","inchiKey":"WSGURAYTCUVDQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165372","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210123","24811413"],"drugbank":["DB04534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697851","canonicalSmiles":"CC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"AIUHRQHVWSUTGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPROPAZATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiopropazate"],"crossReferences":{"drugbank":["DB13557"],"chEBI":["59119"]},"childChemblIds":["CHEMBL3989786"],"count":1,"approvedIndications":["EFO_0005407"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL1723","canonicalSmiles":"COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl","inchiKey":"YTNKWDJILNVLGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFUZOSIN HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL709","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alfutral sr","Alfuzosin hydrochloride","Benestan","Benestan ret","Besavar xl","Fuzatal xl","Kelanu xl","Urion s","Uroxatral","Vasran xl","Xatral","Xatral sr","Zufal xl"],"synonyms":["Alfuzosin hydrochloride","SL 77 499-10","SL-77-499-10","SL-77499-10"],"crossReferences":{"DailyMed":["alfuzosin%20hydrochloride"],"PubChem":["144204252","170465022"],"chEBI":["32286"]},"count":1,"approvedIndications":["EFO_0000284"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0004253","EFO_1001228","EFO_0000284"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for benign prostatic hyperplasia."}
{"id":"CHEMBL174","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"AVKUERGKIZMTKX-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPICILLIN","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amcill","Amfipen","Ampicillin trihydrate","Ampilar","Britcin","Omnipen","Omnipen (ampicillin)","Penbritin","Pfizerpen-a","Polycillin","Principen","Principen '125'","Principen '250'","Principen '500'","Totacillin","Vidopen"],"synonyms":["AY-6108","Alpha-Aminobenzylpenicillin","Amcill","Aminobenzylpenicillin","Ampicillin","Ampicillin/ampicillin trihydrate","Anhydrous ampicillin","BRL-1341","NSC-528986","Omnipen-N","P-50","Penbritin","Penbritin-S","Pfizerpen-A","Polycillin","Polycillin-N","Polycillin-Prb","Principen","Probampacin","Totacillin","Totacillin-N","WY 5103"],"crossReferences":{"DailyMed":["ampicillin%20sodium"],"PubChem":["144206600","144211733","170464831","29215015","56422904","855874"],"Wikipedia":["Ampicillin"],"drugbank":["DB00415"],"chEBI":["28971"]},"childChemblIds":["CHEMBL453388","CHEMBL1200758","CHEMBL1078033"],"count":9,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for bacterial disease and eye infection and has 7 investigational indications."}
{"id":"CHEMBL1742423","canonicalSmiles":"CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21","inchiKey":"ACCMWZWAEFYUGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILASTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilaxten"],"synonyms":["Bilastine"],"crossReferences":{"PubChem":["170466329"],"drugbank":["DB11591"]},"count":5,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","EFO_0007141","EFO_1001417","EFO_0003785","EFO_0003956","EFO_1001881"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for allergy and has 4 investigational indications."}
{"id":"CHEMBL1743063","drugType":"Antibody","blackBoxWarning":false,"name":"RILOTUMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 102","AMG-102","Rilotumumab"],"count":8,"linkedTargets":{"rows":["ENSG00000019991"],"count":1},"linkedDiseases":{"rows":["MONDO_0015917","MONDO_0001056","EFO_0000588","EFO_0000681","EFO_1001465","EFO_0000702","EFO_0000708","MONDO_0008315"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1822792","canonicalSmiles":"CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1","inchiKey":"JGEBLDKNWBUGRZ-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2461","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-2461","Mk-2461"],"count":2,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1823872","canonicalSmiles":"C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O","inchiKey":"NHXLMOGPVYXJNR-ATOGVRKGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SOMATOSTATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SRIF-14","Somatostatin"],"crossReferences":{"drugbank":["DB09099"],"chEBI":["64628"]},"count":13,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL1852688","canonicalSmiles":"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1","inchiKey":"QADPYRIHXKWUSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INFIGRATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGJ-398","BGJ398","Bgj-398","Infigratinib","MVP-BGJ398","NVP-BGJ398"],"crossReferences":{"drugbank":["DB11886"],"chEBI":["63451"]},"childChemblIds":["CHEMBL1834657"],"count":11,"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_15","EFO_0000756","EFO_1002027","Orphanet_44890","MONDO_0007254","MONDO_0044704","EFO_0005221","MONDO_0020654","EFO_0000311","MONDO_0001187","EFO_0001061","EFO_0001668","EFO_0000519"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL18602","canonicalSmiles":"CCCCC=O","inchiKey":"HGBOYTHUEUWSSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTANAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentanal"],"crossReferences":{"PubChem":["144210381","17389654"],"drugbank":["DB01919"],"chEBI":["84069"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186200","canonicalSmiles":"O=[N+]([O-])[O-]","inchiKey":"NHNBFGGVMKEFGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL186200","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14049"],"chEBI":["17632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1899328","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl","inchiKey":"WCPXLMIPGMFZMY-MERQFXBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMOXIPRIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL22242","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56463156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1951914","canonicalSmiles":"CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1","inchiKey":"QOSMEMHKXNNIGG-SSEXGKCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD5672","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5672","AZD5672","Azd 5672","Azd5672"],"count":2,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000685"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2002581","canonicalSmiles":"CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.Cl","inchiKey":"KCRQZLMAZHZDCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFEROXAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL556","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA-29837","Deferoxamine hydrochloride"],"crossReferences":{"PubChem":["570243"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2007389","canonicalSmiles":"CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12.Cl","inchiKey":"LAOOXBLMIJHMFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCANTHONE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL279014","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["79 T61","79-T61","Lucanthone hydrochloride","MS-752","NSC-14574","RP-3735"],"crossReferences":{"PubChem":["540758"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2021342","canonicalSmiles":"Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2","inchiKey":"MSTNYGQPCMXVAQ-KIYNQFGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2021342","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00116"],"chEBI":["20506"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2021424","canonicalSmiles":"O=S(=O)([O-])[O-].[K+].[K+]","inchiKey":"OTYBMLCTZGSZBG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM SULFATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot sulf"],"synonyms":["Potassium sulfate"],"crossReferences":{"drugbank":["DB14499"],"chEBI":["32036"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2010."}
{"id":"CHEMBL2028019","canonicalSmiles":"CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1","inchiKey":"KPWSJANDNDDRMB-QAQDUYKDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARIPRAZINE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reagila"],"synonyms":["Cariprazine","GED-129","MP-214","RGH-188"],"crossReferences":{"DailyMed":["cariprazine%20hydrochloride"],"drugbank":["DB06016"]},"childChemblIds":["CHEMBL2024517"],"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000151577"],"count":2},"linkedDiseases":{"rows":["EFO_0003756","EFO_0000289","MONDO_0002050","MONDO_0002009","EFO_0009963","EFO_0005407","EFO_0010445","EFO_0000692"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for psychosis and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2043437","canonicalSmiles":"CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1","inchiKey":"SFNSLLSYNZWZQG-VQIMIIECSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GLASDEGIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glasdegib","PF-04449913","PF-4449913"],"crossReferences":{"DailyMed":["glasdegib%20maleate"],"drugbank":["DB11978"]},"childChemblIds":["CHEMBL4297534","CHEMBL2043440"],"count":7,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0013730","MONDO_0019457","EFO_0000222","EFO_1001968","EFO_0000519","EFO_1001934","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neoplasm and cancer and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL204997","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3n[nH]c(-c4ccccc4)c3O)nc2c1","inchiKey":"CKSIVONWCYACAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204997","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062335","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"YGULWPYYGQCFMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL TARTRATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arbralene","Beloc cor","Betaloc","Betaloc s.a.","Lopresor","Lopresor sr","Lopressor","Mepranix 100","Mepranix 50","Metoprolol tartrate","Tensomex","Toprol xl"],"synonyms":["CGP-2175E","Metoprolol tartrate"],"crossReferences":{"DailyMed":["metoprolol%20tartrate"]},"count":5,"approvedIndications":["EFO_0000612","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0004269","EFO_0003144","EFO_0001645","EFO_0000612","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for myocardial infarction and hypertension and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2074922","canonicalSmiles":"CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1","inchiKey":"NSVFSAJIGAJDMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFONIDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efonidipine","Efonidipine hydrochloride"],"crossReferences":{"PubChem":["144206968"],"drugbank":["DB09235"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096647","drugType":"Small molecule","blackBoxWarning":false,"name":"LANTHANUM CARBONATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosrenol"],"synonyms":["BAY77-1931","Lanthanum carbonate","Lanthanum carbonate hydrate"],"crossReferences":{"DailyMed":["lanthanum%20carbonate"],"DrugCentral":["4585"]},"childChemblIds":["CHEMBL1909302"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 2 investigational indications."}
{"id":"CHEMBL2104038","canonicalSmiles":"CC(C)OC(=O)OC1CCCCC1","inchiKey":"VTDCYOLLYVAJSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILEXETIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilexetil"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104344","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Na+]","inchiKey":"UEUXEKPTXMALOB-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edetate sodium"],"crossReferences":{"drugbank":["DB13404"]},"childChemblIds":["CHEMBL1871697"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104744","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](C)C[C@@]21C","inchiKey":"IWSXBCZCPVUWHT-VIFKTUCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTOMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norgestomet","SC-21009"],"crossReferences":{"drugbank":["DB11440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105181","canonicalSmiles":"C=C(C#N)C(=O)OCCCCCCCC","inchiKey":"RPQUGMLCZLGZTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCRYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ocrilate","Ocrylate"],"crossReferences":{"drugbank":["DB15086"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105695","canonicalSmiles":"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1","inchiKey":"MDSQOJYHHZBZKA-GBXCKJPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELOTRISTAT ETHYL","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xermelo"],"synonyms":["LX 1032","LX 1606","LX-1032","LX-1606","LX1032","LX1606","Telotristat ethyl"],"crossReferences":{"DailyMed":["telotristat%20etiprate"],"drugbank":["DB12095"]},"childChemblIds":["CHEMBL3348963"],"count":4,"linkedTargets":{"rows":["ENSG00000139287","ENSG00000129167"],"count":2},"linkedDiseases":{"rows":["MONDO_0003060","EFO_1001769","EFO_1000044","EFO_1001901","HP_0002014","MONDO_0002995","EFO_0001421","EFO_1000852"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 investigational indications."}
{"id":"CHEMBL2105759","canonicalSmiles":"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1","inchiKey":"XUZMWHLSFXCVMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BARICITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olumiant"],"synonyms":["Baricitinib","INCB-028050","INCB028050","Incb-28050","LY-3009104","LY3009104"],"crossReferences":{"DailyMed":["baricitinib"],"drugbank":["DB11817"]},"count":16,"approvedIndications":["EFO_0000685","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000685","EFO_1000668","EFO_0000401","EFO_0000274","EFO_0000540","EFO_1001486","EFO_0002609","EFO_0003106","EFO_1001209","EFO_1001231","MONDO_0100096","EFO_0004192","EFO_1001999","EFO_0002690","EFO_0000783","EFO_0000676"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for immune system disease and rheumatoid arthritis and has 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106424","canonicalSmiles":"C=C(C#N)C(=O)OC","inchiKey":"MWCLLHOVUTZFKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECRYLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyanoacrylate","Mecrilate","Mecrylate","Methyl cyanoacrylate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107294","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C/C(=C1/c3ccccc3CSc3ccccc31)C2","inchiKey":"JOQKFRLFXDPXHX-YFUWWQDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPATEPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SD 1248-17 [AS HYDROCHLORIDE]","Tropatepine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107325","canonicalSmiles":"Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O.Cl","inchiKey":"QFRMKDCRDUXTBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABUZALGRON HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL257978","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dabuzalgron hydrochloride","RO 115-1240/190"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107574","canonicalSmiles":"COC1CC(=C(c2cccs2)c2cccs2)C[N+](C)(C)C1.[Br-]","inchiKey":"QTSXMEPZSHLZFF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMEPIDIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1865135","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Timepidium bromide"],"crossReferences":{"PubChem":["144206212","170465823"],"chEBI":["32226"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107774","canonicalSmiles":"CCc1ccc(Nc2c(F)c(F)cc(F)c2F)c(CC(=O)O)c1","inchiKey":"ZEXGDYFACFXQPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROBENACOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Robenacoxib"],"crossReferences":{"drugbank":["DB11455"],"chEBI":["76269"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108678","drugType":"Antibody","blackBoxWarning":false,"name":"NESVACUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Regn910"],"synonyms":["Nesvacumab","REGN-910","REGN910"],"count":2,"linkedTargets":{"rows":["ENSG00000091879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001365","EFO_0009321"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108709","drugType":"Enzyme","blackBoxWarning":false,"name":"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Santyl","Xiaflex"],"synonyms":["AA-4500","AA4500","Clostridium histolyticum enzymes","Collagenase","Collagenase (clostridium histolyticum)","Collagenase clostridium histolyticum","MZ-004"],"crossReferences":{"DailyMed":["collagenase%20clostridium%20histolyticum"],"DrugCentral":["5051"]},"count":10,"approvedIndications":["HP_0200042","HP_0003549","EFO_0004229"],"linkedTargets":{"rows":["ENSG00000108821","ENSG00000204248","ENSG00000060718","ENSG00000188153","ENSG00000168542","ENSG00000164692","ENSG00000206384","ENSG00000163359","ENSG00000142156","ENSG00000081052","ENSG00000204262","ENSG00000169031","ENSG00000172752","ENSG00000080573","ENSG00000197565","ENSG00000142173","ENSG00000215018","ENSG00000204291","ENSG00000130635","ENSG00000171502","ENSG00000139219","ENSG00000196739","ENSG00000182871","ENSG00000134871","ENSG00000187498"],"count":25},"linkedDiseases":{"rows":["EFO_0003899","EFO_0000759","EFO_0005756","EFO_1001459","HP_0200042","HP_0003549","HP_0012227","EFO_0007067","EFO_0009516","MONDO_0043839","EFO_1000941","EFO_1001434","EFO_0004229"],"count":13},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL2108769","drugType":"Unknown","blackBoxWarning":false,"name":"SAW PALMETTO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saw palmetto","Serenoa repens","Serenoa repens fruit","Serenoa repens fruit dry extract","Serenoa repens fruit ethanol extract"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108885","drugType":"Unknown","blackBoxWarning":false,"name":"ACTOVEGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actovegin"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108905","drugType":"Unknown","blackBoxWarning":false,"name":"BCG VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tice bcg"],"synonyms":["Bacillus calmette-guerin vaccine","Bcg vaccine","Tuberculosis vaccine"],"count":13,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL2108955","drugType":"Antibody","blackBoxWarning":false,"name":"EDRECOLOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panorex"],"synonyms":["17-1A","C-1","Edrecolomab","MAB-17-1A"],"count":3,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000364","EFO_1001951","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109121","drugType":"Unknown","blackBoxWarning":false,"name":"DIPHTHERIA TOXOID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphtheria toxoid"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109159","drugType":"Protein","blackBoxWarning":false,"name":"PITRAKINRA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pitrakinra"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL210952","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-YZRLXODZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELTANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eltanolone"],"crossReferences":{"drugbank":["DB12308"],"chEBI":["1712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109523","drugType":"Antibody","blackBoxWarning":false,"name":"M170","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M170"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109547","drugType":"Antibody","blackBoxWarning":false,"name":"ME1-14 F(AB')2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ME1-14 F(AB')2","Me1-14 f(ab')2"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109563","drugType":"Antibody","blackBoxWarning":false,"name":"RAV-12","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RAV-12","Rav-12"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110670","canonicalSmiles":"c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2","inchiKey":"NPTIPEQJIDTVKR-STQMWFEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VABICASERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vabicaserin"],"crossReferences":{"drugbank":["DB12071"]},"childChemblIds":["CHEMBL2104991","CHEMBL3126691"],"count":1,"linkedTargets":{"rows":["ENSG00000135914","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0000692"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2111066","canonicalSmiles":"CC(CN1c2ccccc2Sc2cccnc21)N(C)C","inchiKey":"OQJBSDFFQWMKBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOTHIPENDYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isothipendyl"],"crossReferences":{"drugbank":["DB08802"]},"childChemblIds":["CHEMBL2107246"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2158051","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O","inchiKey":"LSXUTRRVVSPWDZ-MKKUMYSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-406","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-406","At-406","D-1143","DEBIO-1143","Debio 1143","IAP INHIBITOR AT-406","SM-406","Xevinapant"],"childChemblIds":["CHEMBL2158055"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2181753","canonicalSmiles":"CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1","inchiKey":"OPXIRFWNLBDKQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AM-211","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Am-211"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218650","canonicalSmiles":"C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1","inchiKey":"XDAOLTSRNUSPPH-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAMANID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deltyba"],"synonyms":["Delamanid","OPC-67683"],"crossReferences":{"Wikipedia":["Delamanid"],"drugbank":["DB11637"]},"count":4,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL2219423","canonicalSmiles":"Cl.Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl","inchiKey":"YFQJOPFTGMHYNV-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFURESERTIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2219422","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afuresertib hydrochloride","GSK2110183B"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2220442","canonicalSmiles":"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21","inchiKey":"FJLGEFLZQAZZCD-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUVASTATIN","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluvastatin"],"crossReferences":{"DailyMed":["fluvastatin%20sodium"],"chEBI":["38562"]},"childChemblIds":["CHEMBL2218894"],"count":12,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0002689","HP_0003124","EFO_0000756","EFO_0001645","HP_0000802","MONDO_0007254","EFO_0000319","EFO_0000266","EFO_0003882","MONDO_0008315","Orphanet_309005","EFO_0000537","Orphanet_63","EFO_0000195","EFO_0000589","EFO_0004220","EFO_0002614","EFO_0000326","EFO_0003047"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for cardiovascular disease and has 11 investigational indications."}
{"id":"CHEMBL223026","canonicalSmiles":"Oc1ccc(-c2n[nH]c3cc(O)ccc23)c(O)c1","inchiKey":"WLDZDEMGKFWJNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223026","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08048"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL232202","canonicalSmiles":"OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"BJRNKVDFDLYUGJ-RMPHRYRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBUTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbutin","NSC-4036"],"crossReferences":{"PubChem":["144205062","144212745","170465722","93576640"],"Wikipedia":["Arbutin"],"drugbank":["DB11217"],"chEBI":["18305"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2333941","canonicalSmiles":"C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1","inchiKey":"MJQMRGWYPNIERM-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2811376","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.079.793K","LY2811376","Ly-2811376","Ly2811376"],"crossReferences":{"drugbank":["DB13065"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2374961","canonicalSmiles":"CC1=CC[C@@H](C(C)(C)O)C[C@@H]1O","inchiKey":"OMDMTHRBGUBUCO-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2374961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239129","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUMINE ANTIMONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meglumine Antimonate","Meglumine antimonate","N-methylglucamine antimonate"],"crossReferences":{"DrugCentral":["1669"],"Wikipedia":["Meglumine_antimoniate"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL23996","canonicalSmiles":"O=C1CCCC(=O)C1=C(O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]","inchiKey":"PMHVFNYNPNKNRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL23996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL240530","canonicalSmiles":"Cc1ccc(C(=O)N2CCC(Cc3ccccc3)CC2)cc1","inchiKey":"DVOLWKZEIDCCES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07123"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243940","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2cccc(NC3CCCCC3)c2)c1Br","inchiKey":"RXDVFLTWXCTCEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06829"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249837","canonicalSmiles":"C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12","inchiKey":"MHIGBKBJSQVXNH-IWVLMIASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHACYCLINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-2876","Metacycline","Methacycline","Motc"],"crossReferences":{"Wikipedia":["Metacycline"],"drugbank":["DB00931"],"chEBI":["6805"]},"childChemblIds":["CHEMBL2146123"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL25164","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"BJDCWCLMFKKGEE-HVDUHBCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL25164","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Dihydroartemisinin"],"drugbank":["DB11638"],"chEBI":["207229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25263","canonicalSmiles":"O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O","inchiKey":"HZLAWYIBLZNRFZ-VXGBXAGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRIDESAP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPHPC","Cphpc","GSK-2315698","GSK2315698","Gsk2315698","Miridesap","RO-638695","Ro 63-8695"],"crossReferences":{"Wikipedia":["CPHPC"],"drugbank":["DB13087"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL257695","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"OIFWQOKDSPDILA-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDOTHYMIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zidovudine Monophosphate"],"crossReferences":{"drugbank":["DB03666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261777","canonicalSmiles":"c1ccc(-c2ncc(-c3cc[nH]n3)s2)cc1","inchiKey":"NRAHRUHGPGBWSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817033"],"drugbank":["DB07614"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL263376","canonicalSmiles":"NC(=S)Nc1ccccc1","inchiKey":"FULZLIGZKMKICU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLTHIOUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Phenylthiourea","N-Phenyl-Thiourea","N-Phenylthiourea","Phenylthiourea"],"crossReferences":{"PubChem":["144208880","144213315","17388780","17389761","26752856"],"drugbank":["DB03694"],"chEBI":["46261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266459","canonicalSmiles":"Cc1cc(CC(=O)[O-])n(C)c1C(=O)c1ccc(Cl)cc1.[Na+]","inchiKey":"SEEXPXUCHVGZGU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOMEPIRAC SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL19490","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zomepirac Sodium"],"crossReferences":{"PubChem":["11113042","144204557","144204888","144209375","170466073","17388726","49816674","56463539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286497","canonicalSmiles":"O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)CNCC2","inchiKey":"UVSIFVBCHJEYJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08631"]},"childChemblIds":["CHEMBL1788154"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289277","canonicalSmiles":"Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O","inchiKey":"RHMXXJGYXNZAPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMODIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emodin"],"crossReferences":{"PubChem":["11111157","11111158","124880055","124880057","144210197","144213535","17389019","174006698","26753048","47193718","477762","50105616","50105617","85231039","90340961"],"Wikipedia":["Emodin"],"drugbank":["DB07715"],"chEBI":["42223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL300337","canonicalSmiles":"COc1ccc(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)cc1","inchiKey":"KQXVERRYBYGQJZ-WRPDIKACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENALKIREN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-64662","ABBOTT-64662","Enalkiren"],"crossReferences":{"drugbank":["DB03395"],"chEBI":["4787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301267","canonicalSmiles":"CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3","inchiKey":"NLYNIRQVMRLPIQ-XQLAAWPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMOTIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Artemotil"],"crossReferences":{"Wikipedia":["Artemotil"],"drugbank":["DB13851"]},"count":1,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for malaria."}
{"id":"CHEMBL3039517","canonicalSmiles":"Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1","inchiKey":"SYYBDNPGDKKJDU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABUSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IC-83","LY-2603618","LY2603618","Ly-2603618","Rabusertib"],"crossReferences":{"drugbank":["DB11662"]},"count":4,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003860","EFO_0003060","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL307189","canonicalSmiles":"CCC(CC)Nc1cc(C(=O)O)ccc1N1C(=O)CCC1(CO)CO","inchiKey":"BNIJJJRESBVRNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL307189","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03475"],"chEBI":["45265"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137313","canonicalSmiles":"NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1","inchiKey":"ATLYLVPZNWDJBW-KIHHCIJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXELOPRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axelopran","TD-1211"],"crossReferences":{"drugbank":["DB12013"]},"childChemblIds":["CHEMBL3137319","CHEMBL3895543"],"count":1,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3188202","canonicalSmiles":"CCCCCON=O","inchiKey":"CSDTZUBPSYWZDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188202","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210096"],"drugbank":["DB01612"],"chEBI":["55344"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL322241","canonicalSmiles":"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C","inchiKey":"ZILOOGIOHVCEKS-HZFUHODCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELINAVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-670881","SC-52151","Telinavir"],"crossReferences":{"drugbank":["DB12178"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3228489","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c(=O)[nH]1","inchiKey":"UIYWFOZZIZEEKJ-PXBUCIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3228489","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250421","canonicalSmiles":"Nc1n[14cH]n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"NMUSYJAQQFHJEW-SQFOUQQVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250421","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1489","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328910","canonicalSmiles":"O=C(O)c1ccc(O)cc1O","inchiKey":"UIAFKZKHHVMJGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4-DIHYDROXYBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-Dihydroxy-Benzoic Acid","2,4-Dihydroxybenzoic Acid","Beta-Resorcylic Acid"],"crossReferences":{"PubChem":["144209669","17389146","17389389","56314872"],"Wikipedia":["2,4-Dihydroxybenzoic_acid"],"drugbank":["DB02839"],"chEBI":["89942"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301625","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1","inchiKey":"KXBDTLQSDKGAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPEBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-292","CC-292","Spebrutinib"],"crossReferences":{"drugbank":["DB11764"]},"childChemblIds":["CHEMBL3301600"],"count":2,"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000565","EFO_0000685","EFO_0000095","EFO_0000403"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3301680","canonicalSmiles":"CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl","inchiKey":"GSSIWSIRBWAZHG-ACOPVEIWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELAVANCIN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL507870","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vibativ"],"synonyms":["TD-6424","Telavancin hydrochloride"],"crossReferences":{"DailyMed":["telavancin%20hydrochloride"]},"count":1,"approvedIndications":["EFO_1001272"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for bacterial pneumonia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3334624","canonicalSmiles":"Cc1cc(C[C@@H](OC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCOCC3)CC2)cc(C)c1O","inchiKey":"HTLWMOKBJQKDIJ-WJOKGBTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-44370","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 44370 TA","BI-44370-BS","Bi 44370 ta","Bi-44370","J3.353.239C"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL337450","canonicalSmiles":"N#C[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O","inchiKey":"DCYBPMFXJCWXNB-JWIUVKOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-109","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tas 109","Tas-109"],"crossReferences":{"drugbank":["DB11667"]},"childChemblIds":["CHEMBL1204346"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL338667","canonicalSmiles":"O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1","inchiKey":"YUGZHQHSNYIFLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPERODON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diperodon"],"crossReferences":{"PubChem":["29217900"],"drugbank":["DB11513"]},"childChemblIds":["CHEMBL1456312"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545029","canonicalSmiles":"CN1CC2CCN(c3ccc(-c4ccc(-n5ncccc5=O)cc4)cc3)C2C1","inchiKey":"GNIRITULTPTAQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-288","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-288"],"count":2,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545030","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-17216498","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-17216498"],"count":1,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545136","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00337210","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-00337210"],"count":1,"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545403","canonicalSmiles":"CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1","inchiKey":"KLRRGBHZCJLIEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-833923","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-833923","BMS-833923 DIMESYLATE MONOHYDRATE","Bms-833923","XL-139","XL139"],"count":7,"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0003897","Orphanet_377","EFO_0002916","EFO_0000702","EFO_0004193","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL354676","canonicalSmiles":"O=C(Nc1ccccc1)Nc1ccccc1","inchiKey":"GWEHVDNNLFDJLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3-Diphenyl-Urea","1,3-Diphenylurea"],"crossReferences":{"PubChem":["103904380","103904397","144207266","17389030","26747341","93576666"],"drugbank":["DB07496"],"chEBI":["41320"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3560112","canonicalSmiles":"N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"SBENMBSICFIYDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3560112","maximumClinicalTrialPhase":0,"parentId":"CHEMBL765","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170464954"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL357021","canonicalSmiles":"Cc1cccc2sc3nncn3c12","inchiKey":"DQJCHOQLCLEDLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICYCLAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212736","26757226"],"drugbank":["DB02891"],"chEBI":["81783"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3678076","canonicalSmiles":"CCCCOc1cccc(CCNCC(=O)N(C)C)c1","inchiKey":"GRHBODILPPXVKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVENAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evenamide","Nw-3509"],"childChemblIds":["CHEMBL4286909"],"count":1,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000692"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL370100","canonicalSmiles":"CO[C@@H]1[C@@H](CO)O[C@@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O","inchiKey":"QEHOIJJIZXRMAN-QZQSLCQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBECCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rebeccamycin"],"crossReferences":{"Wikipedia":["Rebeccamycin"],"drugbank":["DB14729"],"chEBI":["135511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3706390","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.Cl.O.O","inchiKey":"MPQKYZPYCSTMEI-FLZPLBAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3706390","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707320","canonicalSmiles":"CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O.Cl","inchiKey":"GYABBVHSRIHYJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALECTINIB HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1738797","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alecensa"],"synonyms":["Alectinib hydrochloride"],"crossReferences":{"DailyMed":["alectinib%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003060"],"linkedTargets":{"rows":["ENSG00000165731","ENSG00000171094"],"count":2},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL37161","canonicalSmiles":"COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1","inchiKey":"HDDSHPAODJUKPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panacur"],"synonyms":["Fenbendazole","HOE 881Y"],"crossReferences":{"PubChem":["11112769","124882602","144204200","144212145","170465647","174006199","26746977","855748"],"Wikipedia":["Fenbendazole"],"drugbank":["DB11410"],"chEBI":["77092"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL376488","canonicalSmiles":"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12","inchiKey":"QUIJNHUBAXPXFS-XLJNKUFUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BEDAQUILINE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirturo"],"synonyms":["Bedaquiline","R-207910","R207910","TMC-207","TMC207"],"crossReferences":{"DailyMed":["bedaquiline%20fumarate"],"drugbank":["DB08903"],"chEBI":["72292"]},"childChemblIds":["CHEMBL4524943","CHEMBL2105700"],"count":6,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for tuberculosis and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL377559","canonicalSmiles":"C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)N2.Cl","inchiKey":"OIRUWDYJGMHDHJ-AFXVCOSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETASPIMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1184904","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPI-504","IPI-504 HYDROCHLORIDE","Retaspimycin hydrochloride"],"crossReferences":{"chEBI":["71956"]},"count":10,"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903","Orphanet_44890","MONDO_0007254","EFO_0000673","EFO_0001378","EFO_0000305","EFO_0003085","EFO_0003060","EFO_0002617","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3786307","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"NNRXCKZMQLFUPL-DVQFKIQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3786307","maximumClinicalTrialPhase":0,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833350","canonicalSmiles":"O.O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-]","inchiKey":"SPPNVMTVMQOKSC-UHFFFAOYSA-A","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGALDRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833408","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynese","Riopan"],"synonyms":["AY-5710","Magaldrate","Monalium hydrate"],"crossReferences":{"DrugCentral":["4926"],"drugbank":["DB08938"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3833372","drugType":"Antibody","blackBoxWarning":false,"name":"BRAZIKUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-139","Brazikumab","MEDI-2070","MEDI2070"],"count":2,"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3907479","canonicalSmiles":"Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1","inchiKey":"BEMNJULZEQTDJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3907479","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3915620","canonicalSmiles":"CC#C[C@@H](CC(=O)O)c1ccc(OCc2ccc(CN3CCC4(C=Cc5ccccc54)CC3)cc2)cc1","inchiKey":"FHRWHNJJQGSCQC-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3915620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3945401","canonicalSmiles":"O=S(=O)(O)O[C@H]1[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O","inchiKey":"NBTMNFYXJYCQHQ-GPIVLXJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3945401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989541","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccc(OC)cc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"ULBNWNUHGJLQHO-VKMIBBQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOSERPIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methoserpidine"],"crossReferences":{"drugbank":["DB13631"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989562","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O","inchiKey":"NZMOFYDMGFQZLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAZOSIN HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL611","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benph","Hytrin","Hytrin bph","Terazosin hydrochloride"],"synonyms":["ABBOTT-45975","Terazosin hydrochloride"],"crossReferences":{"DailyMed":["terazosin%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL3989570","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2.O.O.O=S(=O)(O)O","inchiKey":"BXSVDJUWKSRQMD-ITMJLNKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYOSCYAMINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1331216","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anaspaz","Levsin","Levsin sl","Levsinex","Levsinex timecaps","Neoquess","Peptard"],"synonyms":["Hyoscyamine sulfate","Hyoscyamine sulphate"],"count":1,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for urinary tract infection."}
{"id":"CHEMBL3989680","canonicalSmiles":"COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1","inchiKey":"LQJLLAOISDVBJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXOMADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axomadol","BN-110 FREE BASE","BN110 BASE","BN110 FREE BASE","En3324","GRT-151 FREE BASE","GRT0151Y","GRT151 Base","GRT151 FREE BASE"],"childChemblIds":["CHEMBL3976339"],"count":3,"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","HP_0003419","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989686","canonicalSmiles":"CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1","inchiKey":"UXIPFQUBOVWAQW-UEBLJOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFERANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iferanserin","Ven-309"],"crossReferences":{"drugbank":["DB11686"]},"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0009552"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL400520","canonicalSmiles":"OCc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12","inchiKey":"RBLKWWBHDUBPFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06983"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403741","canonicalSmiles":"Nc1ccc(N)cc1","inchiKey":"CBCKQZAAMUWICA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Phenylenediamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Phenylenediamine","P-Phenylenediamine"],"crossReferences":{"PubChem":["144205168","144209191","144213260","170466858","29215299","29215300"],"drugbank":["DB14141"],"chEBI":["51403"]},"childChemblIds":["CHEMBL3561416"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406572","canonicalSmiles":"Cc1ccc(-c2cccc(C(=O)N3CCCC(C)(C)C3)n2)cc1F","inchiKey":"SIDDLTBLAQYZIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406572","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06992"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4085000","canonicalSmiles":"O=[N+]([O-])O.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"LUVLWQYIJIKHLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4085000","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL419667","canonicalSmiles":"COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC","inchiKey":"CEBYCSRFKCEUSW-NAYZPBBASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELCOVAPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relcovaptan","Sr-49059","TDI 0134"],"crossReferences":{"PubChem":["26753276"],"Wikipedia":["Relcovaptan"],"drugbank":["DB13929"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4207489","canonicalSmiles":"N#Cc1cc(NC(=O)[C@H]2c3ccccc3C(=O)N(CC(F)(F)F)[C@@H]2c2cccnc2)ccc1F","inchiKey":"VKCPFWKTFZAOTO-LEWJYISDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SJ-733","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SJ733","Sj-733","Sj733"],"crossReferences":{"drugbank":["DB12659"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4228124","canonicalSmiles":"COc1ccc2c(c1)CC[C@H](CN(C)CC(=O)O)[C@@H]2c1ccccc1","inchiKey":"UEBBYLJZCHTLEG-UTKZUKDTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORG-25935","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORG 25935","Org 25935","Org-25935","SCH 900435","SCH-900435","Sch 900435"],"crossReferences":{"drugbank":["DB12220"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL429713","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(C)CC1.O=C(O)C(=O)O","inchiKey":"GHTBEZCRTKFPIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PETHIDINE OXALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL607","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["meperidine oxalate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297473","canonicalSmiles":"Cc1occc1C(=O)Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2ccccc12","inchiKey":"XLLRLAABUFOJPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NP-G2-044","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NP-G2-044","Np-g2-044"],"crossReferences":{"drugbank":["DB14995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297502","canonicalSmiles":"C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC","inchiKey":"TUWMKPVJGGWGNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVORALSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avoralstat","BCX-4161"],"crossReferences":{"drugbank":["DB12120"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297588","canonicalSmiles":"CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(=O)O)c3ccc(O)cc3)cc2S(=O)(=O)N1","inchiKey":"XULSCZPZVQIMFM-IPZQJPLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODEVIXIBAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-4250","A4250","AR-H064974","AZD-8294","AZD8294","Odevixibat"],"count":4,"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["Orphanet_30391","Orphanet_79304","MONDO_0001751","EFO_0004267","Orphanet_172","EFO_1001249","Orphanet_79306"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297828","drugType":"Unknown","blackBoxWarning":false,"name":"SHR-1316","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HTI-1088","SHR-1316","Shr-1316"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297909","drugType":"Unknown","blackBoxWarning":false,"name":"BFKB-8488A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BFKB-8488A","BFKB8488A","Bfkb-8488a","Bfkb8488a","RG-7992","RG7992"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297945","drugType":"Unknown","blackBoxWarning":false,"name":"EFMOROCTOCOG ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efmoroctocog alfa","Efraloctocog alfa","Elocta"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298026","drugType":"Unknown","blackBoxWarning":false,"name":"MCMV-3068A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mcmv-3068a","Mcmv3068a"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298077","drugType":"Antibody","blackBoxWarning":false,"name":"PRASINEZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX002","Prasinezumab","Prx002","RG-7935","RG7935","RO-7046015","RO7046015","Ro7046015"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL430497","canonicalSmiles":"Clc1ccc(OC[C@H]2CCN2)cn1","inchiKey":"MKTAGSRKQIGEBH-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEBANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tebanicline"],"childChemblIds":["CHEMBL2104964"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL436462","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"MWEWSHNGVWABKG-SVBPBHIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL436462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01908"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455186","canonicalSmiles":"CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O","inchiKey":"YCPOZVAOBBQLRI-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREOSULFAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-39069","Treosulfan"],"crossReferences":{"drugbank":["DB11678"],"chEBI":["82557"]},"count":15,"approvedIndications":["EFO_0000616","EFO_0002422"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and benign neoplasm and has 13 investigational indications."}
{"id":"CHEMBL458875","canonicalSmiles":"Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O","inchiKey":"GBBJCSTXCAQSSJ-XQXXSGGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEVUDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clevudine","L-FMAU","Levovir"],"crossReferences":{"Wikipedia":["Clevudine"],"drugbank":["DB06683"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594521","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 330","AMG-330","Amg 330","Amg-330"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594550","drugType":"Antibody","blackBoxWarning":false,"name":"SERPLULIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-10","HLX10","Hlx10","Serplulimab"],"count":5,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL473159","canonicalSmiles":"Oc1cc(O)cc(O)c1","inchiKey":"QCDYQQDYXPDABM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHLOROGLUCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spasfon","Spasfon-lyoc"],"synonyms":["NSC-1572","Phloroglucinol"],"crossReferences":{"PubChem":["29218028"],"Wikipedia":["Phloroglucinol"],"drugbank":["DB12944"],"chEBI":["16204"]},"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL474637","canonicalSmiles":"Cc1cc(N)nc(C[C@H]2CNC[C@H]2NCCNCc2ccc(Cl)cc2)c1","inchiKey":"JDRSQGJWTVRNGM-QFBILLFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474637","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08018"]},"childChemblIds":["CHEMBL481815"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485980","canonicalSmiles":"CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC","inchiKey":"CJGYSWNGNKCJSB-YVLZZHOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLADESINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucladesine","Bucladesine sodium"],"crossReferences":{"PubChem":["11113333","144204415","26751474"],"Wikipedia":["Bucladesine"],"drugbank":["DB13242"],"chEBI":["50095"]},"childChemblIds":["CHEMBL1522836","CHEMBL1876736"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL487182","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2","inchiKey":"AEQDJSLRWYMAQI-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROPALMATINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Tetrahydropalmatine","L-Tetrahydropalmatine","Tetrahydropalmatine","Tetrahydropalmatine l-form"],"crossReferences":{"Wikipedia":["Tetrahydropalmatine"],"drugbank":["DB12093"],"chEBI":["16563"]},"childChemblIds":["CHEMBL1359254"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL491019","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1","inchiKey":"SVMHTBVIPYVDIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1107","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-1107"],"crossReferences":{"drugbank":["DB08459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492320","canonicalSmiles":"CC(C)(C)c1ccc(C(=O)N/N=C/c2cc(Br)c(O)c(Br)c2O)cc1","inchiKey":"FVJUELRQTOWYRY-ZVBGSRNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL492320","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL493982","canonicalSmiles":"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1","inchiKey":"ZBGXUVOIWDMMJE-QHNZEKIYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORAPAXAR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["SCH-530348","Vorapaxar"],"crossReferences":{"DailyMed":["vorapaxar%20sulfate"],"Wikipedia":["Vorapaxar"],"drugbank":["DB09030"],"chEBI":["82702"]},"childChemblIds":["CHEMBL3542336","CHEMBL2107386"],"count":3,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","EFO_0000712","EFO_0001645","MONDO_0002679","EFO_0000612","HP_0004419","EFO_0005672","EFO_0004265"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for recurrent thrombophlebitis and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL494163","canonicalSmiles":"Cl.N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"WIJHFFBIVJGJJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL55","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-125857"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL509027","canonicalSmiles":"O=C(O)c1ccc[nH]1","inchiKey":"WRHZVMBBRYBTKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509027","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02543"],"chEBI":["36751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL51483","canonicalSmiles":"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O","inchiKey":"QBKSWRVVCFFDOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOSSYPOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Gossypol","BL-193","Gossypol","NSC-56817","NSC-624336"],"crossReferences":{"PubChem":["104171302","106063","11112318","11114252","124882242","124882244","124882245","124882246","144203985","170466800","26747182","26747183","26752256","26752257","50104971","8139932","90341416"],"Wikipedia":["Gossypol"],"drugbank":["DB13044"]},"childChemblIds":["CHEMBL1516388"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL516","canonicalSmiles":"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1","inchiKey":"JJCFRYNCJDLXIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROHEPTADINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyproheptadine"],"crossReferences":{"DailyMed":["cyproheptadine%20hydrochloride"],"PubChem":["104171133","11110964","11110965","11113362","124879679","144203663","170465127","174007288","26751603","50100203","50104260","90341656"],"Wikipedia":["Cyproheptadine"],"drugbank":["DB00434"],"chEBI":["4046"]},"childChemblIds":["CHEMBL1716"],"count":4,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","EFO_0003766","EFO_0003785","EFO_0000311","EFO_0003829"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for allergy and has 3 investigational indications."}
{"id":"CHEMBL52333","canonicalSmiles":"CCCn1c(=O)c2nc(C34CC5CC(CC3C5)C4)[nH]c2n(CCC)c1=O","inchiKey":"PJBFVWGQFLYWCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLOFYLLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KW 3902","KW-3902","MK-7418","Rolofylline"],"crossReferences":{"PubChem":["137275983"]},"count":2,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL539843","canonicalSmiles":"Cl.Cl.NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1","inchiKey":"BOYLPLUVCXUHDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAPITADINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL369075","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hivenyl"],"synonyms":["R129160","Vapitadine dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL560377","canonicalSmiles":"c1ccc2nc(COc3ccc(-c4n[nH]cc4-c4ccncc4)cc3)ccc2c1","inchiKey":"VRWJZGHUCOFGPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL560377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL565612","canonicalSmiles":"CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1","inchiKey":"OAVGBZOFDPFGPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTRASTAURIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEB-071","AEB071","Aeb-071","NVP-AEB071","Sotrastaurin"],"crossReferences":{"PubChem":["103905056"],"drugbank":["DB12369"],"chEBI":["90531"]},"childChemblIds":["CHEMBL2105655"],"count":5,"linkedTargets":{"rows":["ENSG00000154229","ENSG00000065675","ENSG00000171132","ENSG00000126583","ENSG00000067606","ENSG00000163932","ENSG00000166501","ENSG00000163558","ENSG00000027075","ENSG00000115825","ENSG00000184304"],"count":11},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000616","EFO_0000403","EFO_0000574","EFO_0000676","EFO_1001119"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL573306","canonicalSmiles":"COc1cc([C@H](C)C#Cc2c(C)nc(N)nc2N)ccc1-c1ccccc1","inchiKey":"YYCPXVRHQUEVAW-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573306","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL575448","canonicalSmiles":"C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1","inchiKey":"LQVXSNNAFNGRAH-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-754807","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-754807","Bms-754807"],"crossReferences":{"PubChem":["164339435"],"drugbank":["DB15399"],"chEBI":["88339"]},"childChemblIds":["CHEMBL2401777"],"count":2,"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL589092","canonicalSmiles":"O=C(O)Cc1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1","inchiKey":"JIEKMACRVQTPRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTIAZAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fentiazac","WY-21,894"],"crossReferences":{"PubChem":["124894583","144205341","144206769","144206770","170466003","99360853"],"drugbank":["DB13217"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL592054","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1COc1ccc(CO/N=C(\\CCC(=O)O)c2ccccc2)cc1","inchiKey":"ULVDFHLHKNJICZ-QCWLDUFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imiglitazar","TAK-559","Tak-559"],"crossReferences":{"drugbank":["DB12511"]},"count":1,"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL596802","canonicalSmiles":"CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1","inchiKey":"YGKUEOZJFIXDGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDOPIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Huntexil"],"synonyms":["ACR-16","ACR16","FR-310826","FR310826","Pridopidine"],"crossReferences":{"drugbank":["DB11947"]},"childChemblIds":["CHEMBL2105691"],"count":2,"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0002508","EFO_0000253"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL621","canonicalSmiles":"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12","inchiKey":"PHLBKPHSAVXXEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAZODONE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desyrel","J10.767K","Trazodone","Trialodine"],"crossReferences":{"DailyMed":["trazodone%20hydrochloride"],"PubChem":["11111900","11111901","174007449","90341328"],"Wikipedia":["Trazodone"],"drugbank":["DB00656"],"chEBI":["9654"]},"childChemblIds":["CHEMBL1200798"],"count":12,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0005687","MONDO_0002009","HP_0000726","EFO_0000249","EFO_0008568","EFO_0004698","EFO_0003829","EFO_1000783","MONDO_0002050","EFO_0003761","EFO_0000253","EFO_0005230","EFO_0000692","EFO_0003918"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for unipolar depression and depressive disorder and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL669","canonicalSmiles":"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21","inchiKey":"JURKNVYFZMSNLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBENZAPRINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclobenzaprine","Flexeril","MK-130 (AS THE BASE)","TNX-102"],"crossReferences":{"DailyMed":["cyclobenzaprine%20hydrochloride"],"PubChem":["11110649","11110650","174007219","4253288","50108641","50111010","90340629"],"Wikipedia":["Cyclobenzaprine"],"drugbank":["DB00924"],"chEBI":["3996"]},"childChemblIds":["CHEMBL1200636"],"count":5,"linkedTargets":{"rows":["ENSG00000102468","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["HP_0001257","EFO_0001422","HP_0003326","EFO_0005687","MONDO_0002050","EFO_0003821","EFO_0009488","EFO_1000632","HP_0003419","EFO_0001358","EFO_0003843"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 investigational indications."}
{"id":"CHEMBL77996","canonicalSmiles":"O=P(O)(O)/C=C/CCSc1ccccc1O","inchiKey":"GHNIEXOPSISMGX-XVNBXDOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL77996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07890"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL84","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1","inchiKey":"UCFGDBYHRUNTLO-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOPOTECAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hycamtin","Potactasol"],"synonyms":["Hycamtin","NSC-609699","SKF-104864","Topotecan"],"crossReferences":{"DailyMed":["topotecan%20hydrochloride"],"PubChem":["164339428"],"Wikipedia":["Topotecan"],"drugbank":["DB01030"],"chEBI":["63632"]},"childChemblIds":["CHEMBL1607"],"count":10,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000184428"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001075","EFO_0003859","EFO_0000681","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0005952","EFO_0000565","MONDO_0002974","EFO_1001331","MONDO_0008903","EFO_0002918","Orphanet_654","EFO_0001416","EFO_0000198","EFO_0003893","EFO_0000466","MONDO_0018271","EFO_0000220","EFO_1000823","MONDO_0008170","EFO_0000502","MONDO_0008315","Orphanet_357034","MONDO_0015917","EFO_0000630","Orphanet_398934","EFO_0001061","EFO_1001100","EFO_0003851","EFO_0008524","EFO_0002428","EFO_0000574","EFO_0001378","EFO_1000172","MONDO_0015686","EFO_1001465","MONDO_0007254","Orphanet_790","MONDO_0021063","MONDO_0002087","EFO_1000357","EFO_0007362","MONDO_0002158","EFO_1000043","EFO_0000326","EFO_0002499","EFO_1001963","EFO_1000158","EFO_0000616","EFO_1001042","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000174","MONDO_0011962","EFO_0000702","EFO_1002008","MONDO_0019004","EFO_0003833","MONDO_0024880","EFO_0000691","EFO_0000519"],"count":68},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for cancer and neoplasm and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL895","canonicalSmiles":"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"NETZHAKZCGBWSS-CEDHKZHLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALBUPHINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nalbuphine","Nubain"],"crossReferences":{"DailyMed":["nalbuphine%20hydrochloride"],"PubChem":["144205561"],"Wikipedia":["Nalbuphine"],"drugbank":["DB00844"],"chEBI":["7454"]},"childChemblIds":["CHEMBL1396398","CHEMBL1201132"],"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0000989","MONDO_0026045","EFO_0005323","EFO_0001421","EFO_0000222","EFO_0005611","EFO_0009267","EFO_0003843","EFO_1001250"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL92","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"ZDZOTLJHXYCWBA-VCVYQWHSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOCETAXEL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["RP-56976","Taxotere"],"crossReferences":{"DailyMed":["docetaxel"],"PubChem":["124950708","144206334","144206639","170464919","494081"],"Wikipedia":["Docetaxel"],"drugbank":["DB01248"],"chEBI":["4672"]},"childChemblIds":["CHEMBL3545252"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003891","EFO_0000637","EFO_0003859","EFO_0000756","EFO_0000681","EFO_0004228","EFO_1000984","EFO_1001951","EFO_0000178","MONDO_0021310","EFO_0000564","MONDO_0002974","MONDO_0008903","MONDO_0001528","EFO_0008528","MONDO_0002038","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0006911","HP_0002039","EFO_1001968","MONDO_0008315","EFO_0001663","MONDO_0002691","Orphanet_398934","MONDO_0018201","EFO_1000527","EFO_0004284","EFO_0000574","EFO_0001378","EFO_0001376","EFO_1000412","EFO_0000292","EFO_0005577","MONDO_0021117","MONDO_0007254","EFO_0004252","MONDO_0020654","EFO_0003817","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0000196","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0005088","EFO_0006859","EFO_1000601","EFO_0002916","Orphanet_44890","MONDO_0007576","EFO_0000304","MONDO_0002120","MONDO_0011962","EFO_0000199","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_0004281","EFO_0000571","MONDO_0004222","EFO_0000228","MONDO_0003212","EFO_0000565","MONDO_0002352","MONDO_0002358","EFO_0000182","MONDO_0003199","HP_0012378","EFO_0001416","Orphanet_145","EFO_1000595","EFO_0003893","EFO_0000466","MONDO_0008170","EFO_0005842","EFO_0007355","EFO_0009708","MONDO_0044787","EFO_1001100","EFO_0005537","HP_0004326","EFO_0002428","EFO_0000233","EFO_0000432","EFO_1000613","EFO_0006544","MONDO_0021355","EFO_0003785","EFO_1000172","EFO_0002938","MONDO_0004192","EFO_0003866","EFO_0004230","EFO_0000708","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_0000305","EFO_1000357","MONDO_0001187","EFO_0007362","EFO_1001480","EFO_1000044","EFO_1000043","MONDO_0001475","EFO_0003860","EFO_0006352","EFO_0000673","EFO_1001963","EFO_0002617","EFO_0002914","MONDO_0001402","EFO_0000503","EFO_0000313","EFO_0003060","EFO_1001214","EFO_0000311","EFO_0005570","EFO_0003863","EFO_0003865","EFO_0010282","EFO_0006861","MONDO_0003219","MONDO_0001325","EFO_0000691","EFO_0000181"],"count":134},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996. This drug has a black box warning from the FDA."}
{"id":"CHEMBL920","canonicalSmiles":"C[N+](C)(C)CCO","inchiKey":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Choline"],"crossReferences":{"PubChem":["11110922","90340588"],"Wikipedia":["Choline"],"drugbank":["DB00122"],"chEBI":["15354"]},"childChemblIds":["CHEMBL4297301"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL923","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O","inchiKey":"IIDJRNMFWXDHID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISEDRONIC ACID","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Actonel","M05BA07","NE-58095","Risedronate","Risedronic acid"],"crossReferences":{"DailyMed":["risedronate%20sodium"],"PubChem":["29216086"],"Wikipedia":["Risedronic_acid"],"drugbank":["DB00884"],"chEBI":["8869"]},"childChemblIds":["CHEMBL4303174","CHEMBL3560765","CHEMBL1654"],"count":12,"approvedIndications":["EFO_0004260"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0004261","MONDO_0021117","EFO_1001919","MONDO_0007254","Orphanet_249","EFO_0004260","HP_0003418","Orphanet_666","EFO_0003882","MONDO_0008315","EFO_1001152","EFO_0000565","HP_0000938","EFO_0003854","EFO_0003957","EFO_0000196","EFO_0000574","EFO_0004215","MONDO_0002635","EFO_0003922"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for bone disease and has 11 investigational indications."}
